D.S. David: Interferon alpha-2b and ribavirin for the treatment of chronic hepatitis C in long-term survivors of bone marrow transplantation (In press; presented at the 1999 Rebetron ® Investigators’ Meeting, Palm Desert, California).

C.S. Murakami, W. Louie, G.S. Chan, M. O’Donnell, D. S. David, S.J. Forman and G.B. McDonald: Biliary obstruction in hematopoietic cell transplant recipients: an uncommon diagnosis with specific causes. Bone Marrow Transplantation 1999; 23: 921-927.

D.S. David, B.R. Tegtmeier et al.: Visceral varicella-zoster after bone marrow transplantation: Report of a case series and review of the literature. American Journal of Gastroenterology 1998; 93 (5): 810-813.

D.S. David (senior contributor): The Clinician’s Companion II: Expert Perspectives on Contemporary Clinical Issues in Hepatitis C, The Education Initiative in Gastroenterology, 1998.

D.S. David (contributor) : The Clinician’s Companion: Expert Perspectives on Contemporary Clinical Issues in Hepatitis C, The Education Initiative in Gastroenterology, 1997.

D. David, H. Mertz et al.: Sleep and duodenal motor activity in patients with severe non-ulcer dyspepsia. Gut 1994; 35: 916-925.

D.S. David, P. Guth and A.H. Soll: Interferon alpha-2b for the treatment of chronic hepatitis B and C: Clinical experience from a large VA Medical Center treatment program. Seminars in Hepatology 1992; 18(2): 104-111.

D.S. David, M.C. Chen and A.H. Soll: Transferrin is an autocrine factor governing growth of canine mucosal cells in culture. Gastroenterology 1991; 100 (5)

This is a partial list. Full publicatons list available upon request. Information on this page may be self-reported and subject to change at any time. Last updated 06/08.